Aug. 11, 2004 — Nanosphere Inc. has expanded one federal project and received a grant for another, according to a news release. The Northbrook, Ill., firm received a contract from the U.S. Government Tactical Support Working Group (TSWG), with whom it started working in 2002 on a field-deployable system to detect DNA sequences of biological warfare agents.
The expansion follows a $2.5 million contract from TSWG to develop a system that enables emergency and hospital personnel to identify biological toxins. Nanosphere also received a $750,000, Phase II grant from the National Institute of Allergy and Infectious Diseases to develop and evaluate diagnostic tests for biological warfare agents, including anthrax and plague. The company will integrate DNA barcode technology and automated microfluidic assay processing into its platform to simplify identification of targets, the release said.